Get started
Author

Rikke Hald

Observed name: R Hald
Institution: Symphogen (Denmark)
ORCID: 0009-0003-8806-9124
Observed ORCID: 0009-0003-8806-9124
OpenAlex ID: A5069313460
Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer
2015 · Rodrigo Dienstmann, Amita Patnaik, et al. · Cancer Discovery · 77
Sym015: A Highly Efficacious Antibody Mixture against MET -Amplified Tumors
2017 · Thomas Tuxen Poulsen, Michael Monrad Grandal, et al. · Clinical Cancer Research · 49
Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumors
2019 · Lene Alifrangis, Rik Schoemaker, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 4
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
2026 · Francois Ghiringhelli, Richard Kim, et al. · Journal for ImmunoTherapy of Cancer · 3
PDF
Abstract CT133: A phase 1b multicenter study of anti-TIM3 (S095018/Sym023) in combination with anti-PD1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
2024 · Francois Ghiringhelli, Richard Kim, et al. · Cancer Research · 3
Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al. · Clinical Cancer Research · 2
Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
2009 · L Heslet, R Hald, et al. · Critical Care · 1
PDF
Supplementary Table S6 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S4 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S2 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S1 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S8 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S9 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S5 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S1 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S9 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S8 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S7 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S3 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S6 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S5 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S10 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Data from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S7 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S4 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Works count: 46
Citation count: 139
H-index: 3
I10-index: 2
Year
Topic
Type